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Abstract 
Introduction: The aims of the present study were to provide reference values for time to exhaustion 
(TTE) on a modified Balke treadmill protocol, and to perform a cross-validation of TTE as a measure 
of maximal oxygen consumption (VO2max), in Norwegian men and women 20 – 85 years of age. 
Methods: Reference values for TTE were derived from a national sample of 765 subjects. An 
additional sample of 119 subjects was included in the cross-validation (total n = 884), where 
prediction equations for VO2max was established. Results: A decline in TTE was seen with increased 
age. Prediction of VO2max in an independent dataset (n = 319) resulted in a R2 = 0.78 and standard 
error of the estimate = 4.55 ml kg-1 min-1. The observed – predicted bias was small (mean difference < 
1.24 ml kg-1 min-1), whereas random error was considerable (95% limits of agreement ± 7.11 – 9.70 
ml kg-1 min-1) across age in both men and women. Conclusions: Despite limitations concerning the 
prediction of VO2max on an individual level, TTE from the Balke protocol is a good measure of aerobic 
fitness in adults across a range of settings, and could be evaluated according to the suggested 
reference values.  
Keywords: Maximal graded treadmill protocol; Aerobic capacity; VO2max; Validity;   
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Introduction 
Aerobic fitness is strongly associated with health and longevity (Kodama et al., 2009; Barry et al., 
2014), and is often an important outcome in exercise interventions. Thus, accurate determination of 
aerobic fitness is important in a range of clinical- and study settings. Maximal oxygen consumption 
(VO2max) measured directly during a maximal treadmill or cycle protocol is generally considered the 
gold standard measure of aerobic fitness. However, due to the need for sophisticated and expensive 
equipment along with skilled personnel to measure VO2max directly, a wide array of test protocols 
that estimate aerobic fitness are available across populations and settings (Jorgensen et al., 2009; 
Solway et al., 2001; Fletcher et al., 2013), because of these tests simpler administration and superior 
feasibility.  
Despite VO2max being regarded as the gold-standard for measurement of aerobic fitness, most 
evidence linking aerobic fitness to health are based on time to exhaustion (TTE) (or other 
performance measures, e.g., final stage or maximal load) on graded treadmill exercise protocols. For 
instance, the largest and possibly most influential study cohort in terms of establishing aerobic 
fitness as a strong predictor of longevity, the Cooper Center Longitudinal Study (CCLS) (previously the 
Aerobics Center Longitudinal Study (ACLS)) (Blair et al., 1996; Blair et al., 1989; Wei et al., 1999), rely 
on TTE determined from the Balke treadmill protocol (Balke and Ware, 1959). Time to exhaustion on 
this protocol compares well with directly measured VO2max (r = 0.72 – 0.94 and standard error of the 
estimate (SEE) = 2.2 – 4.3 ml kg-1 min-1) (Froelich and Lancaste, 1974; Froelicher et al., 1975; Pollock 
et al., 1976; Pollock et al., 1982). Nonetheless, due to the unambiguous relationship with health 
(Blair et al., 1996; Blair et al., 1989; Wei et al., 1999), TTE as determined from the Balke protocol is 
arguable a valid measure of aerobic fitness. Moreover, when compared to each other, directly 
measured VO2max and performance measures has been shown to be of similar prognostic value 
regarding mortality (Kavanagh et al., 2002; Goel et al., 2011) and of similar predictive value regarding 
sport performance (Hawley and Noakes, 1992; Noakes et al., 1990). Thus, performance on a graded 
maximal exercise protocol are a feasible and valid measure of aerobic fitness across a range of 
settings. Importantly, the Balke protocol are well suited in clinical settings due to its initial stages 
being of low intensity and as it does not requires running. 
Recently, Edvardsen et al. (2013) published reference values for VO2max, but not TTE, in a 
representative sample of Norwegian men and women 20 – 85 years of age based on a modified Balke 
treadmill protocol. To the best of our knowledge, reference values for TTE as obtained from a Balke 
protocol has not been published in women or subjects older than 55 years. Therefore, to make 
results obtained without direct measurement of O2-consumption informative, the main aim of the 
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present study was to provide reference values for TTE from the modified Balke protocol in 
Norwegian adults. Moreover, we are not aware of any previous studies that have performed a cross-
validation of TTE obtained from a Balke protocol for prediction of VO2max. A secondary aim was 
therefore to perform a cross-validation of TTE against VO2max in this large sample.  
 
Methods 
Subjects 
The present study is based on two datasets: a national sample (n = 904) and an additional sample (n 
= 159) recruited at one of the nine test centers that provided data for the national sample. The 
national sample is based on a large multicenter cross-sectional study to determine physical activity, 
aerobic fitness and determinants of physical activity in a representative sample of 20 – 85 year old 
Norwegians. Please see Hansen et al. (2012) and Edvardsen et al. (2013) for detailed information 
regarding the sample underlying the present data. In short, 1930 out of the 3485 subjects who 
initially provided data on objectively measured physical activity were invited to perform direct 
measurements of VO2max, of which 904 undertook the examination.  
The additional sample comprised 159 (out of 262 randomly invited) subjects, aged 40 – 43 and 53 – 
54 years, who were invited for a direct measurement of VO2max and assessment of risk factors for 
cardiovascular diseases at one of the test centers (Solbraa et al., 2011).  
Both studies were approved by the Regional Medical Ethics Committee and all subject provided 
written informed consent prior to participation. 
 
Test protocol 
Before undertaking the maximal treadmill test, subjects were screened, and those having two or 
more risk factors for cardiovascular disease combined with an age > 50 years of age or a blood 
pressure > 180/110 mmHg were excluded from performing the maximal test.  
Prior to the maximal treadmill protocol, subjects performed 2 – 7 minutes of self-paced walking on a 
level treadmill. After the familiarization, the treadmill was set to a start inclination of 4% and a start 
speed of 3.8 km per hour (km h-1) (≥ 55 years old) or 4.8 km h-1 (< 55 years old), and the subjects 
walked for 4 minutes (i.e., warm-up was included in the protocol). Thereafter, the elevation 
increased by 2% every minute until a maximal inclination of 20% was reached. The most fit subject 
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(those exceeding a test-duration of 12 minutes) thereafter received an increased speed of 0.5 km h-1 
until exhaustion. 
Oxygen consumption was measured using three types of gas analyzers across the nine test centers: 
Oxycon Pro (Erich Jaeger GmbH, Hoechberg, Germany; n = 2), Vmax Sensormedics (CareFusion 
Corporation, San Diego, USA; n = 6) and Moxus Modular VO2 system (AEI Technologies Inc, 
Pittsburgh, USA; n = 1). Volume and gas calibrations were performed daily according to the 
manufacturers’ recommendations. In addition, all analyzers were checked for measurement 
precision and accuracy at two different time points with a standardized motorized mechanical lung 
(Motorized Syringe with Metabolic Calibration Kit; VacuMed, Ventura, USA) and/or a human 
calibrator, and a correction factor was applied for each gas analyzer to ensure comparable data 
between the test laboratories (range 0.925 – 1.059). In addition, all lab technicians involved in the 
data collection were experienced technicians and rigorously trained in the test procedures, and the 
nine treadmills were pre-programmed to ensure that identical exercise protocols were used across 
all labs. VO2max was reported as the mean oxygen uptake over a 30 second interval, whereas TTE was 
reported to the nearest 30 seconds. A test was considered valid (maximal) if individuals had a 
respiratory exchange ratio (RER) ≥1.10 or a rate of perceived exertion (RPE) ≥ 17 (Borg6-20 scale) (Borg, 
1970). These end criteria was applied as they have been shown to be valid in this specific sample 
(Edvardsen et al, 2014), to end up with a reasonable sample size, and for the present results to align 
with the previously published reference values for VO2max (Edvardsen et al., 2013). 
Physical activity was measured using the Actigraph GT1M accelerometer (ActiGraph, LLC, Pensacola, 
Florida, USA), as previously described (Hansen et al., 2012). Body mass and height was measured at 
the test centers. Overweight and obesity were defined as exhibiting a body mass index (BMI) ≥ 25 
and 30 kg m-2, respectively. Education level, ethnicity, smoking habits and prevalence of diabetes 
type 2 was self-reported. 
 
Statistical analyses 
The subject characteristics are presented as the mean values and standard deviation (SD).  
Reference values were based on the national sample only, to retain the representativeness of the 
sample. Mean values and the 10 – 90 percentile range (mean ± 1.282 · SD of the residuals) for 5-year 
age groups (20 – 24 years, 25 – 29 years, etc.] were based on a linear mixed model determining the 
association between age and TTE in men and women for the low-and high intensity protocols 
6 
 
separately, including test center as a random effect. The quadratic effect of age was tested in all 
models, and retained in the model(s) if statistically significant. 
The cross-validation of TTE as a measure of VO2max were based on both datasets, and assessed in 
several steps. First, we split our sample to construct one training dataset (~2/3 of the subjects, n = 
567) and one testing dataset (~1/3 of the subjects, n = 317). Second, we tested the TTE · sex 
interaction in each of the two age-groups (including TTE, sex, age, body mass, and TTE · sex as 
independent variables) in the training dataset. Third, equations to predict VO2max from TTE in the 
training dataset was made separately in each sex- and age-group using the following model: VO2max = 
b0 + b1 · TTE + b2 · body mass + b3 · age. Fourth, the predicted and measured VO2max were compared 
in the testing dataset using linear regression, Bland-Altman plots and 95% limits of agreement (LoA [= 
SD of the differences · 1.96)]) (Bland and Altman, 1986). Finally, we calculated new sex- and age-
specific equations to predict VO2max from TTE, body mass and age based on the whole sample. All 
equations for estimating VO2max were constructed using a linear mixed model, to take into account 
the clustering of observations within each test center. However, prediction models were evaluated 
using ordinary least squares regression to avoid overfitting of the model, as variance among test 
centers will be unknown in future prediction models. 
The impact on TTE and VO2max of using RPE 17 vs. 18 – 20 and 17 vs. 19 – 20 to accept a maximal 
effort was analyzed using a linear mixed model including test center as a random effect and protocol, 
age and sex as fixed effects. 
All analyses were performed using SPSS v. 23 (IBM SPSS Inc., Armonk, New York, USA). A p-value < 
.05 indicated statistically significant findings. 
 
Results 
Of the 1063 subjects that met for the examination of aerobic fitness, 22 subjects were excluded for 
having a high cardiovascular disease risk. Additionally, VO2max measurements were unavailable for 16 
subjects due to technical problems. Finally, 141 subjects were excluded for not achieving the criteria 
for maximal effort. Reasons for ending the test prematurely were various combinations of poor 
motivation, medical problems or discomfort during testing (mainly musculoskeletal pain, dizziness or 
problems with maintaining balance), or discomfort wearing the face mask required for the 
measurement of VO2max. Thus, a total of 884 subjects (448 men and 436 women) were included in the 
present analyses (83% of those meeting for the examination). Of these, 765 subjects (402 men and 
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363 women) were from the national representative sample, and served as subjects for establishing 
the reference values for TTE (table 1). The additional sample (n = 119) exhibited a higher physical 
activity level (20 – 32%, p < .001) and improved aerobic fitness (6 – 16%, p < .003) compared to the 
national sample.  
 
Reference values for TTE 
Table 2 shows reference values for TTE on the two protocols (i.e., start speed 3.8 and 4.8 km h-1) for 
men and women. Men exhibited a longer test-duration than women in both age-groups. The 25 – 34 
year old men and women exhibited the best performance, whereas a decline in performance was 
seen with increased age. The relationship with age was quadratic in the youngest age-group (p = .018 
and .013 for age2 in men and women, respectively) and linear in the oldest age-group (p = .859 and 
.988 for age2 in men and women, respectively). Thus, reference values and the 80% reference range 
across age-groups (table 2; figure 1) was based on the following models: Men 20 – 54 years: TTE = 
11.99 (6.33 – 17.65) + 0.27 (-0.02 – 0.57) · age - 0.00448 (-0.00819 - -0.00078) · age2 (SEE = 2.23, n = 
242); Women 20 – 54 years: TTE = 10.37 (5.14 – 15.60) + 0.26 (-0.02 – 0.53) · age -  0.00446 (-0.00798 
- -0.00094) · age2 (SEE = 2.21, n = 223); Men 55 – 85 years: TTE = 21.38 (17.70 – 25.05) -0.11 (-0.16 - -
0.05) · age (SEE = 2.13, n = 160); Women 55 – 85 years: TTE = 23.06 (19.41 – 26.71) -0.17 (-0.22 - -
0.11) · age (SEE = 2.50, n = 140). 
 
Cross-validation of TTE as a measure of VO2max 
Training dataset equations: Splitting of the dataset left 567 subjects (286 men and 281 women; 363 
20 – 54 year olds and 204 55 – 85 year olds) in the training dataset and 317 subjects (162 men and 
155 women, 220 20 – 54 year olds and 97 55 – 85 year olds) in the testing dataset. In the training 
dataset, we found a significant sex · TTE interaction for prediction of VO2max in the youngest age-
group (β (95% CI) -0.55 (-0.95 – -0.15, p = .007), whereas the interaction was weaker and non-
significant (-0.22 (-0.64 – 0.19), p = .284) in the oldest age-group. Despite the weaker sex-specific 
effect in the oldest age-group, all equations were determined separately for men and women 
(Supporting information table 1).  
Cross-validation performance: In the total sample of men and women of all ages (n = 319) the model 
fit indicated a small amount of shrinkage when predicted values was used to model the observed 
values of VO2max, leaving R2 = 0.78 and SEE = 4.55 ml kg-1 min-1 (p < .001). Corresponding values were 
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R2 = 0.73 and SEE = 4.97 ml kg-1 min-1 in the 20 – 54 year old men, R2 = 0.59 and SEE = 4.66 ml kg-1 
min-1 in the 20 – 54 year old women, R2 = 0.65 and SEE = 3.67 ml kg-1 min-1 in the 55 – 85 year old 
men, and R2 = 0.57 and SEE = 3.97 ml kg-1 min-1 in the 55 – 85 year old women (p < .001 for all 
models). Prediction of VO2max from TTE resulted in a bias (95% confidence interval) ± 95% limits of 
agreement of 0.10 (-0.84 – 1.03) ± 9.70 ml kg-1 min-1 in the 20 – 54 year old men, -0.16 (-1.06 – 0.74) 
± 9.29 ml kg-1 min-1 in the 20 – 54 year old women, 1.24 (0.22 – 2.27) ± 7.11 ml kg-1 min-1 in the 55 – 
85 year old men, and 0.76 (-0.43 – 1.96) ± 7.90 ml kg-1 min-1 in the 55 – 85 year old women (figure 1). 
The bias varied from -4.00 (-5.05 – -2.93) to 3.55 (2.48 – 4.63) ml kg-1 min-1 across the test centers, 
when all age- and gender groups were merged. As the derived equations performed sufficiently well 
in the cross-validation, we established final equations based on the whole sample (table 3).  
An examination of RPE in relation to performance showed that subjects that reported maximal 
values of 17 (n = 297) was not significantly different from those reporting values of 18-20 (mean [95% 
CI] TTE: -0.18 [-0.53 – 0.16] min, p = .309; VO2max: -0.33 [-1.40 – 0.74] ml kg-1 min-1, p = .543, n = 442) 
or 19-20 (TTE: -0.19 [-0.61 – 0.23] min, p = .377; VO2max: -0.04 [-1.32 – 1.25] ml kg-1 min-1, p = .952, n = 
216). 
 
Discussion 
The present study provides reference values for performance on a modified Balke treadmill protocol 
in a large sample of Norwegian men and women aged 20 – 85 years. The 25 – 34 year old men and 
women exhibited the best performance, whereas a decline in performance was observed with 
increased age. Results from the cross-validation showed that TTE can be used as an accurate 
measure of VO2max on a group-level across age and gender. Yet, one must be aware of a substantial 
amount of noise when predicting VO2max on an individual level. Nevertheless, prediction of VO2max 
from performance on the modified Balke protocol would not be necessary in most settings, as TTE 
can be used directly and interpreted against the reference values presented herein.  
The original Balke protocol (start speed 5.3 km h-1 at a level treadmill; 1% increased inclination per 
minute) has shown to result in exhaustion at (median (10 – 90 percentile)) 17.5 (14 – 21), 16.5 (13 – 
20) and 15.5 (12 – 19) minutes in 25 – 34, 35 – 44 and 45 – 54 year old men, respectively (Wolthuis et 
al., 1977). The protocol applied in the present study makes use of an increase in inclination of 2% 
every minute, but had a lower speed of walking than that of the original protocol (Balke and Ware, 
1959). As a result, our findings in the 20 – 54 year old men compares well with TTE using the original 
Balke protocol (Balke and Ware, 1959; Wolthuis et al., 1977). To the best of our knowledge, 
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reference values have not been published in women or subjects older than 55 years. The lower 
treadmill speed used in subjects aged 55 – 85 years (3.8 km h-1), led to test durations being quite 
similar to that of their younger counterparts (using a treadmill speed of 4.8 km h-1). The long test 
duration might however constitute a problem with respects to the determination of maximal aerobic 
capacity in fit subjects, whose TTE greatly exceeds the recommended duration of 6 – 12 minutes of a 
test to determine aerobic fitness using a graded maximal exercise protocol (Fletcher et al., 2013; 
Buchfuhrer et al., 1983). Thus, for example the Bruce protocol has been shown to produce higher 
VO2max values than the Balke protocol in both men and women (Pollock et al., 1976; Pollock et al., 
1982; Froelicher et al., 1975). Interestingly, Froelicher et al. (1975) did only find this difference in fit 
subjects. Nevertheless, underestimation of aerobic fitness in fit subjects are arguably not a big 
concern, as fit subjects are normally not those to target by exercise interventions aimed at improving 
health outcomes.  
Previous studies using graded treadmill protocols have shown correlations of r = 0.72 – 0.92 and SEE 
= 3.95 – 4.26 ml kg-1 min-1 compared with directly measured VO2max in men (Froelich and Lancaste, 
1974; Froelicher et al., 1975; Pollock et al., 1976), and r = 0.94 and SEE = 2.20 ml kg-1 min-1 in women 
(Pollock et al., 1982). The SEEs found in the training dataset in the present study were in the range of 
3.36 ml kg-1 min-1 for the oldest women to 4.71 ml kg-1 min-1 for the youngest men. However, the SEE 
in the youngest men was reduced to 4.14 ml kg-1 min-1 when we excluded three subjects for having 
residuals for predicting VO2max < -15 ml kg-1 min-1 (results not shown). These subjects’ oxygen uptake 
might have been underestimated due to unnoticed technical errors. Nevertheless, findings from the 
cross-validation were identical when these subjects were excluded, thus all subjects were kept in the 
training model as well as in the final model.  
As expected, the cross-validation revealed a moderate degree of shrinkage of the model fit in most 
groups. As far as we are aware, no previous study has performed a cross-validation of a Balke 
protocol for prediction of VO2max. Yet, our findings concerning the validity of the Balke protocol seem 
to be quite similar to results from previous studies of cross-validation of the 20 meter shuttle run test 
and maximal cycle ergometer tests in adults (Aandstad et al., 2011; Malek et al., 2004; Lockwood et 
al., 1997; Santtila et al., 2013; Green et al., 2013). However, samples varying with respect to size, 
gender, age, training status and health, along with disparate ways of reporting the findings, make 
comparisons between studies difficult. We found minimal biases in all groups, although somewhat 
larger biases were observed in the oldest age groups (being statistically significant in the 55 – 85 year 
old men), compared to the younger groups. A plausible explanation is that the oldest age groups 
were more prone to bias, because the smaller sample size of both the training- and the testing 
dataset (n less than one-half of that of the younger age groups) lead to more unstable results than in 
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the younger age groups. These results indicate that TTE, on a group level, was an accurate predictor 
of VO2max in the present study. However, the biases varied between test centers with a magnitude 
quite similar to biases reported in previous external validation studies (~5 ml kg-1 min-1) (Aandstad et 
al., 2011; Green et al., 2013; Malek et al., 2004). Given the measurement error of O2-analyzers 
(Hodges et al., 2005), variation in execution of protocols, and often relatively small and 
homogeneous samples used for deriving or testing equations, biases in predictions are expected. The 
somewhat greater cluster effect found for prediction models for VO2max (ICC = 0.08 – 0.19) compared 
to TTE (ICC = 0.02 – 0.14) in the presents study (results not shown), despite rigid corrections of 
VO2max-results using a mechanical lung among the nine test centers involved in the study, supports a 
possible lack of agreement between O2-analyzers.  
Despite good accuracy, the precision of the prediction of VO2max from TTE on an individual level was 
clearly less than perfect, as individual errors (i.e., LoA) of up to approximately ± 10 and ± 8 ml kg-1 
min-1 must be expected in the younger and older age groups, respectively. Across the age- and 
gender groups this error equals ± 1.0 to 1.3 times the sample SDs for VO2max. Random error in 
previous external cross-validation studies varies from SEEs ~2.5 to 4.2 ml kg-1 min-1 (Green et al., 
2013; Malek et al., 2004; Lockwood et al., 1997) or LoA ~6 – 9 ml kg-1 min-1 (Aandstad et al., 2011; 
Santtila et al., 2013), thus our results seem to be in the middle- to upper range of these previous 
studies. Contrary to most previous studies which have used trained subjects or athletes, however, we 
report on a representative sample of men and women 20 – 85 years of age whose fitness and 
physical activity levels varies greatly. As reliability is a premise for validity, and athletes are more 
reliable than non-athletes (Hopkins et al., 2001), the lower and more variable training status of the 
subjects comprising the present data is a plausible explanation for the slightly poorer validity found. 
It is also reasonable to believe that the greater variation in training status might have introduced 
greater variation in work economy compared to previous studies (Lacour and Bourdin, 2015; Morgan 
et al., 1995). Accounting for work economy (and a plateau in VO2max) has previously been shown to 
decrease the SEE of a prediction model for VO2max from TTE on a graded maximal treadmill test from 
4.82 to 3.27 ml kg-1 min-1 in children (Aadland et al., 2014). Moreover, as discussed above, variation 
in the measurement of O2-consumption between test centers will clearly influence our estimates of 
precision, as an ordinary linear regression model was used for the cross-validation. Actually, if data 
was tested using a mixed model (thus accounting for the differences between the test centers), the 
precision of the model improved by almost 20% (SEE = 3.76 vs. 4.55 ml kg-1 min-1, results not shown).  
The magnitude of the random error found in the present- and previous studies, clearly shows that 
predicted levels of VO2max on an individual level must be interpreted carefully. Large errors on an 
individual level are a great problem in epidemiology, as it increases the probability of performing 
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type II errors (Hutcheon et al., 2010). Still, as hypothesized previously (Aadland et al., 2014), TTE and 
VO2max as obtained from a maximal graded treadmill protocol are different measures of aerobic 
fitness, of which both are measured with error, and both performs well as markers of health status 
(Goel et al., 2011; Kavanagh et al., 2002) and sport performance (Hawley and Noakes, 1992; Noakes 
et al., 1990). Therefore, we caution against use of VO2max values predicted from TTE on an individual 
level.  
Reliance on TTE, as opposed to determination of VO2max, causes a loss of two frequently used criteria 
to verify a maximal exertion from graded maximal protocols; the obtainment of a plateau in O2-
consumption despite an increased work load, and RER-levels above a certain threshold. Yet, which 
criteria that should be applied and how they should be defined are highly debated (Edvarsen et al, 
2014). Determination of blood lactate concentration could be an alternative, however, in many 
settings where measurement of VO2max is excluded for not being feasible, measurement of the 
lactate concentration would probably also be inconvenient. Maximal heart rate is simple to measure, 
but exhibit great variation at maximal effort, thus, despite frequently being applied, it is not 
recommended as a criterion to verify maximal exertion (Fletcher et al., 2013; Edvardsen et al., 2014). 
The American Heart Association recommends using RPE (Borg6-20 scale) ≥ 18 as a threshold for a valid 
test (Fletcher et al., 2013). We found a significantly lower performance of those reporting Borg 
values of 15 or 16 compared to those reporting values ≥ 17, but did not find any evidence of a 
decreased performance of those reporting a Borg value of 17 compared to ≥ 18 (TTE reduced by ~11 
seconds). Thus, guided by our findings, in lack of measurement of O2-consumption we recommend a 
Borg value of 17 being used as a criterion to verify a maximal exertion. Importantly, ~34% of the 
present sample obtained a RPE of 17, thus applying a stricter criterion will cause a substantial loss of 
subjects having a valid test result. 
 
Strengths and limitations 
A strength of the present study is the inclusion of a large sample of adults and older men and 
women. Reference values based on performance on a Balke protocol has not previously been 
determined in subjects older than 54 years (Balke and Ware, 1959; Wolthuis et al., 1977). A 
limitation, though, is that the present results is based on a subsample exhibiting a higher physical 
activity level and a lower BMI compared to the larger sample of 3485 subjects from where the 
sample was randomly drawn from (Hansen et al., 2012). Also, education level and prevalence of 
diabetes type 2 and smoking indicate that, especially the older age group, were a selected group 
comparing favorably to Norwegian population estimates. Finally, the BMI of both men and women 
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were ~1 – 2 kg m-2 lower compared with data from a large population study in Norway (the HUNT 3 
study) (Midthjell et al., 2013), and ethnic groups other than Caucasians were under-sampled. Taken 
together, this implies that our reference values might be somewhat overestimated. To determine the 
impact of the higher physical activity level and lower BMI in the present sample compared to current 
population estimates, we re-analyzed the TTE reference values adding BMI and physical activity level 
(overall cpm as obtained by accelerometry) as predictors to the models (p ≤ .002 for both predictors 
across all models). Replacing mean values from the present sample with physical activity levels 
reduced by 10% (~-35 cpm) and BMI increased by 5% (~1.3 units) resulted in a decreased TTE of 26 to 
35 seconds across the groups (results not shown). Thus, it is reasonable to believe that the 
Norwegian population level of TTE is approximately one-half a minute less than the reference values 
suggested by the present study.   
Another limitation of the present study is the lack of data on reliability of the modified Balke protocol 
investigated. There is, however, little reason to believe that the reliability of TTE would be weaker 
than that of VO2max (Hopkins et al., 2001; Bosquet et al., 2008; Scott et al., 2015). According to 
Hopkins (Hopkins et al., 2001), who reviewed different measures of reliability, incremental tests 
provided coefficients of variation (CV) < 8% for all outcomes, with CVs for performance measures 
being 50% lower than those of VO2max. As previously discussed, discrepancies might be due to 
challenges related to calibration of equipment (Hodges et al., 2005; Hopkins et al., 2001). Though, it 
should be mentioned that some studies have found a significant learning effect of TTE, but not for 
VO2max (Bensimhon et al., 2008), however, other studies have indicated the opposite (Scott et al., 
2015), or no learning effect for either measure (Bosquet et al., 2008). In any case, appropriate study 
designs would minimize challenges related to possible test-retest biases.  
We regard the use of national data collected from nine test centers from all parts of Norway a 
strength of the study. Thus, the results are obtained by many technicians, using nine different 
treadmills and three different types of O2-analyzers. As discussed, this has probably caused 
conservative estimates of the measurement properties, thus we believe the reported findings should 
be representative to most new test settings.  
 
Perspectives 
Performance on the graded maximal treadmill protocol used in the present study, is a feasible and 
good measure of aerobic fitness that is suitable in many settings (e.g., clinical, within fitness centers 
and in large population based studies). The reliance on the Balke protocol in the CCLS being the 
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largest study cohort that include measurement of aerobic fitness and unambiguously showing clear 
relationships between aerobic fitness and health (Blair et al., 1996; Blair et al., 1989; Wei et al., 
1999), are strong arguments to support its use in large studies. Because the protocol do not require 
running (for those having a poor fitness level) and has a slow increase in work load, it is well suited to 
evaluate aerobic fitness in populations heterogeneous in terms of fitness level, age, adiposity or 
health status in general (Fletcher et al., 2013). To provide an easy way of using and comparing results 
from the protocol to Norwegian reference values for TTE and VO2max, the equations provided in this 
paper is made available through the following web-page (a beta version): http://fitness.hisf.no. We 
hope the reference values provided can make the suggested protocol more easily applied, and found 
superior to other submaximal and/or indirect tests having poor or unknown measurement 
properties.  
 
 
Conclusion 
We provide reference values for TTE obtained from a modified Balke treadmill protocol in a large 
sample of Norwegian men and women, and we cross-validated performance on the protocol as a 
measure of VO2max. Despite precautions should be taken when aiming to predict VO2max on an 
individual level, we suggest that using TTE from the Balke protocol presented herein is a feasible and 
good measure of aerobic fitness in adults across a range of settings. Still, as for all exercise testing 
procedures, precautions must be taken when applying the test in clinical settings (Fletcher et al., 
2013).  
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Table 1. Subject characteristics for the national sample (n = 765) by sex and age. All values are mean (SD) or 
frequency. 
 Men Women 
Age group (years) 20-54 55-85 20-54 55-85 
n* 242 160 223 140 
Age (years) 40.4 (8.8) 64.4 (6.2) 40.7 (9.2) 65.8 (7.9) 
Height (cm) 180.3 (6.3) 178.1 (7.0) 167.4 (6.3) 164.6 (6.1) 
Body mass (kg) 84.6 (12.2) 84.9 (11.5) 70.2 (12.9) 68.2 (10.3) 
BMI (kg m-2) 26.0 (3.5) 26.7 (3.1) 25.0 (4.4) 25.2 (3.7) 
Overweight/obese (%) 43.0/12.8 57.5/11.9 25.1/14.8 35.7/9.3 
Physical activity (cpm) 370 (128) 345 (134) 363 (119) 337 (123) 
VO2max (ml kg-1 min-1) 43.4 (9.3) 33.1 (6.3) 35.0 (7.2) 27.4 (5.9) 
VO2max (l min-1) 3.61 (0.63) 2.79 (0.51) 2.41 (0.44) 1.84 (0.38) 
TTE (min) 15.3 (2.4) 14.2 (2.5) 13.1 (2.4) 11.9 (2.9) 
RER (ratio) 1.23 (0.09) 1.17 (0.11) 1.21 (0.10) 1.17 (0.12) 
RPE (Borg 6-20 scale) 17.8 (1.2) 17.4 (1.3) 17.5 (1.4) 17.5 (1.1) 
HRmax (beats min-1) 184.8 (12.9) 162.8 (15.5) 181.8 (10.2) 164.8 (13.4) 
Plateau (%) 44 43 44 43 
Education level (%)     
  < High school 14.5 7.0 10.5 14.1 
  High school 38.6 28.7 37.9 31.9 
  University < 4 years 21.2 24.8 25.6 23.7 
  University ≥ 4 years 25.7 39.5 26.0 30.4 
Caucasian origin (%) 99.1 100 99.0 100 
Smokers (%) 12.4 16.5 17.3 16.5 
Diabetes type 2 (%) 4.2 3.9 1.8 2.2 
BMI = body mass index; MVPA = moderate to vigorous physical activity; VO2max = maximal oxygen consumption; 
TTE = time to exhaustion; RER = respiratory exchange ratio; RPE = rate of perceived exertion; HRmax = maximal 
heart rate; *total n = 710 – 765 across variables. 
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Table 2. Reference values and 80% reference range for test duration (minutes) on a modified Balke treadmill 
protocol across age-groups in men and women.  
Age group (years) Men Women 
 Age-predicted mean 10 – 90 percentile Age-predicted mean 10 – 90 percentile 
     
 Protocol; start speed 4.8 km h-1 
20-24 15.8 12.9 – 18.7 14.0 11.1 – 16.8 
25-29 16.0 13.2 – 18.9 14.1 11.3 – 17.0 
30-34 16.0 13.2 – 18.9 14.1 11.3 – 16.9 
35-39 15.8 13.0 – 18.7 13.8 11.0 – 16.7 
40-44 15.4 12.5 – 18.2 13.4 10.5 – 16.2 
45-49 14.7 11.8 – 17.6 12.7 9.8 – 15.5 
50-54 13.8 11.0 – 16.7 11.7 8.9 – 14.6 
     
 Protocol; start speed 3.8 km h-1 
55-59 15.1 12.3 – 17.8 13.3 10.1 – 16.5 
60-64 14.5 11.8 – 17.2 12.4 9.2 – 15.6 
65-69 14.0 11.2 – 16.7 11.6 8.4 – 14.8 
70-74 13.4 10.7 – 16.1 10.7 7.5 – 13.9 
75-79 12.9 10.1 – 15.6 9.9 6.7 – 13.1 
80-85 12.3 9.6 – 15.0 9.0 5.8 – 12.2 
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Table 3. Final equations to estimate VO2max (ml kg-1 min-1) from TTE and body mass by sex and age based on the 
total dataset. Regression coefficients are reported as estimate (95% CI). 
 Men Women 
 Age < 55 Age ≥ 55 Age < 55 Age ≥ 55 
n 288 160 295 141 
Intercept 22.04 (13.28 – 30.79) 40.05 (26.96 – 53.13) 23.03 (16.49 – 29.56) 39.67 (30.06 – 49.28) 
Age (years) -0.18 (-0.25 – -0.12) -0.27 (-0.39 – -0.16) -0.15 (-0.21 – -0.09) -0.25 (-0.34 – -0.17) 
Body mass (kg) -0.13 (-0.18 – -0.08) -0.13 (-0.19 – -0.07) -0.10 (-0.14 – -0.06) -0.13 (-0.19 – -0.07) 
TTE (minutes) 2.61 (2.33 – 2.89) 1.49 (1.17 – 1.82) 1.95 (1.71 – 2.20) 1.07 (0.82 – 1.31) 
SEE (ml kg-1 min-1) 4.46 3.91 3.87 3.19 
TTE = time to exhaustion; SEE = standard error of the estimate 
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Supporting information table 1. Equations to estimate VO2max (ml kg-1 min-1) from TTE and body mass by sex and 
age based on the training dataset. Regression coefficients are reported as estimate (95% CI). 
 Men Women 
 Age < 55 Age ≥ 55 Age < 55 Age ≥ 55 
n 177 109 186 95 
Intercept 25.21 (12.88 – 37.54) 39.74 (22.13 – 57.35) 22.81 (14.32 – 31.30) 37.50 (24.95 – 50.05) 
Age (years) -0.20 (-0.29 – -0.11) -0.28 (-0.44 – -0.12) -0.15 (-0.23 – -0.08) -0.24 (-0.36 – -0.13) 
Body mass (kg) -0.14 (-0.21 – -0.07) -0.12 (-0.20 – -0.03) -0.12 (-0.17 – -0.07) -0.13 (-0.20 – -0.05) 
TTE (minutes) 2.52 (2.11 – 2.93) 1.47 (1.06 – 1.88) 2.09 (1.77 – 2.41) 1.15 (0.82 – 1.47) 
SEE (ml kg-1 min-1) 4.71 4.05 3.87 3.36 
TTE = time to exhaustion; SEE = standard error of the estimate 
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Figure legends 
Figure 1. The relationship between age and TTE. a) 20 – 54 year old men: TTE = 11.99 (6.33 – 17.65) + 0.27 (-
0.02 – 0.57) · age - 0.00448 (-0.00819 – -0.00078) · age2 (SEE = 2.23, ICC = 0.03, n = 242); Women 20 – 54 years: 
TTE = 10.37 (5.14 – 15.60) + 0.26 (-0.02 – 0.53) · age -  0.00446 (-0.00798 – -0.00094) · age2 (SEE = 2.21, ICC = 
0.01, n = 223); Men 55 – 85 years: TTE = 21.38 (17.70 – 25.05) -0.11 (-0.16 – -0.05) · age (SEE = 2.13, ICC = 0.14, 
n = 160); Women 55 – 85 years: TTE = 23.06 (19.41 – 26.71) -0.17 (-0.22 – -0.11) · age (SEE = 2.50, ICC = 0.03, n 
= 140).The bold line shows the trend for age, whereas the dotted lines show the 80% reference range (the 10 – 
90 percentile). TTE = time to exhaustion; SEE = standard error of the estimate; ICC = intra-class correlation 
 
Figure 2. Agreement for observed versus predicted VO2max. Bland Altman plot showing the observed - predicted 
VO2max from TTE as a function of the mean of the two values in the testing dataset based on the regression 
equations derived from the training dataset (see supporting information table 1). The solid line is the mean 
difference; the dotted line is the 95% limits of agreement (bias ± 1.96 SD of the difference). VO2max = maximal 
oxygen consumption 
 


